Comprehensive Healthcare Systems, Inc. (TSXV:CHS)
Canada · Delayed Price · Currency is CAD 0.3950
-0.0500 (-11.24%)
Sep 11, 2026, 3:59 PM EST
TSXV:CHS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.37 | 4.12 | 3.77 | 3.84 | 4.3 | 4.5 | |
Revenue Growth | 8.78% | 9.32% | -1.73% | -10.90% | -4.26% | -5.09% |
Cost of Revenue | 1.84 | 1.68 | 1.71 | 2.68 | 2.9 | 3.13 |
Gross Profit | 2.53 | 2.44 | 2.06 | 1.15 | 1.4 | 1.37 |
Selling, General & Admin | 2.93 | 2.51 | 2.11 | 3.43 | 5.73 | 3.34 |
Research & Development | 1.38 | 0.76 | 0.52 | 0.49 | 0.49 | 0.39 |
Operating Expenses | 4.9 | 3.63 | 3.04 | 4.49 | 6.55 | 4.01 |
Operating Income | -2.37 | -1.19 | -0.98 | -3.33 | -5.15 | -2.64 |
Interest Expense | -0.22 | -0.39 | -0.33 | -0.28 | -0.28 | -2.11 |
Interest & Investment Income | - | - | - | - | 0.01 | 0.01 |
Currency Exchange Gain (Loss) | - | - | - | - | -0.05 | 0.05 |
Other Non Operating Income (Expenses) | 0.44 | 0.12 | 0.13 | 0.03 | - | 0.75 |
EBT Excluding Unusual Items | -2.15 | -1.47 | -1.18 | -3.58 | -5.46 | -3.94 |
Other Unusual Items | -0.68 | -0.68 | 0.57 | - | 0.35 | -0.98 |
Pretax Income | -2.83 | -2.14 | -0.61 | -3.58 | -5.11 | -4.93 |
Net Income | -2.85 | -2.14 | -0.61 | -3.58 | -5.11 | -4.93 |
Net Income to Common | -2.85 | -2.14 | -0.61 | -3.58 | -5.11 | -4.93 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 22 | 15 | 6 | 6 | 4 | 2 |
Shares Outstanding (Diluted) | 22 | 15 | 6 | 6 | 4 | 2 |
Shares Change | 19.99% | 136.26% | - | 69.64% | 141.99% | 38.64% |
EPS (Basic) | -0.13 | -0.15 | -0.10 | -0.58 | -1.40 | -3.26 |
EPS (Diluted) | -0.13 | -0.15 | -0.10 | -0.58 | -1.40 | -3.26 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.77 | -0.79 | 0.34 | -1.23 | -4.04 | -3.34 |
Free Cash Flow Per Share | -0.13 | -0.05 | 0.06 | -0.20 | -1.10 | -2.21 |
Gross Margin | 57.96% | 59.17% | 54.71% | 30.11% | 32.58% | 30.39% |
Operating Margin | -54.31% | -28.88% | -25.99% | -86.88% | -119.53% | -58.70% |
Profit Margin | -65.28% | -52.05% | -16.12% | -93.39% | -118.66% | -109.55% |
Free Cash Flow Margin | -63.49% | -19.10% | 9.01% | -32.05% | -93.81% | -74.26% |
EBITDA | -2.37 | -1.17 | -0.96 | -3.32 | -5.13 | -2.63 |
EBITDA Margin | -54.16% | -28.29% | -25.40% | -86.54% | -119.16% | -58.50% |
D&A For EBITDA | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 |
EBIT | -2.37 | -1.19 | -0.98 | -3.33 | -5.15 | -2.64 |
EBIT Margin | -54.31% | -28.88% | -25.99% | -86.88% | -119.53% | -58.70% |
Advertising Expenses | - | - | - | - | - | 0.51 |